
SOURCE:
Joel Kramer, UCSF Professor of Neuropsychology and the Director of the Memory and Aging Center Neuropsychology program. In this video, he explores the underlying biological mechanisms of cognitive aging, and interventions that may optimize cognitive functioning as we age.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
October is Lewy Body Dementia Awareness Month! See what you can learn and how you can help.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On
I have taken a great number of on-line classes. NONE of them compare with the knowledge obtained through this video. Thank you for making it available!